Xencor, Inc Increase (Decrease) in Loans, Deferred Income
Xencor, Inc (XNCR) reported Increase (Decrease) in Loans, Deferred Income of $0 for the 9-month period ending 2024-09-30, per its 10-Q/A filed 2025-02-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInLoansDeferredIncome · last filed 2025-02-24
- Xencor, Inc increase (decrease) in loans, deferred income for the quarter ending 2024-09-30 was $0.00.
- Xencor, Inc increase (decrease) in loans, deferred income for the quarter ending 2024-06-30 was $0.00.
- Xencor, Inc increase (decrease) in loans, deferred income for the quarter ending 2024-03-31 was $0.00.
- Xencor, Inc increase (decrease) in loans, deferred income for the quarter ending 2023-12-31 was $0.00.
- Xencor, Inc increase (decrease) in loans, deferred income for fiscal 2023 was $0.00.
- Xencor, Inc increase (decrease) in loans, deferred income for fiscal 2022 was $0.00.
- Xencor, Inc increase (decrease) in loans, deferred income for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Loans, Deferred Income 3 month | Increase (Decrease) in Loans, Deferred Income 3 month as first filed | Increase (Decrease) in Loans, Deferred Income 6 month | Increase (Decrease) in Loans, Deferred Income 6 month as first filed | Increase (Decrease) in Loans, Deferred Income 9 month | Increase (Decrease) in Loans, Deferred Income 9 month as first filed | Increase (Decrease) in Loans, Deferred Income 12 month | Increase (Decrease) in Loans, Deferred Income 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-02-24 | $0.00 derived: sum of 2 quarters · filed 2025-02-24 | $0.00 10-Q/A · filed 2025-02-24 | $24.89M 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2024-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-02-24 | $0.00 10-Q/A · filed 2025-02-24 | $16.31M 10-Q · filed 2024-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-02-24 | $0.00 derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2024-03-31 | $0.00 10-Q/A · filed 2025-02-24 | $9.41M 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-24 | $0.00 derived: sum of 3 quarters · filed 2025-02-24 | $0.00 derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $0.00 derived: sum of 2 quarters · filed 2025-02-24 | $0.00 derived: sum of 3 quarters · filed 2025-02-24 | $0.00 10-K/A · filed 2025-02-24 | -$156.87M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | |||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | ||||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |||||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |